Ataxia-telangiectasia (A-T), an autosomal recessive disease caused by mutations in the ATM gene is characterised by cerebellar atrophy and progressive neurodegeneration which has been poorly recapitulated in Atm mutant mice. Consequently, pathways leading to neurodegeneration in A-T are poorly understood. We describe here the generation of an Atm knockout rat model that does not display cerebellar atrophy but instead paralysis and spinal cord atrophy, reminiscent of that seen in older patients and milder forms of the disorder. Loss of Atm in neurons and glia leads to accumulation of cytosolic DNA, increased cytokine production and constitutive activation of microglia consistent with a neuroinflammatory phenotype. Rats lacking ATM had significant loss of motor neurons and microgliosis in the spinal cord, consistent with onset of paralysis. Since short term treatment with steroids has been shown to improve the neurological signs in A-T patients we determined if that was also the case for Atm-deficient rats. Betamethasone treatment extended the lifespan of Atm knockout rats, prevented microglial activation and significantly decreased neuroinflammatory changes and motor neuron loss. These results point to unrepaired damage to DNA leading to significant levels of cytosolic DNA in Atm-deficient neurons and microglia and as a consequence activation of the cGAS-STING pathway and cytokine production. This in turn would increase the inflammatory microenvironment leading to dysfunction and death of neurons. Thus the rat model represents a suitable one for studying neurodegeneration in A-T and adds support for the use of anti-inflammatory drugs for the treatment of neurodegeneration in A-T patients. † These authors contributed equally to this work.
Introduction
Activation of the DNA damage response (DDR) has been shown to have a protective effect against inflammation-driven conditions such as cancer, infection, airway mucosal injury and sepsis (1, 2) . Mutations in genes involved in the DDR give rise to a number of human genetic disorders characterised by genome instability, immunodeficiency, cancer predisposition and neurodegeneration (3, 4) . Characteristic of these is the autosomal recessive disorder ataxia-telangiectasia (A-T), which features radiosensitivity, defects in cell cycle control and DNA repair associated with increased risk of cancer and progressive neurodegeneration (5, 6) . ATM, the protein mutated in A-T, is a protein kinase present in both the nucleus and cytoplasm, which is activated by ionizing radiation and agents that alter chromatin structure (7, 8) . As part of the process of activation by DNA damage, ATM undergoes monomerization from a dimeric form and becomes autophosphorylated, which enables it to phosphorylate a multitude of protein substrates that function in several cellular processes including cell cycle control, DNA repair, transcriptional control, class switch recombination and in response to infection (9, 10) . ATM is also activated by oxidative stress independent of DNA damage (11) . Exposure of cells to H 2 O 2 leads to ATM activation by a mechanism involving the formation of an ATM dimer held together by a disulphide bridge (11) . It seems likely that ATM is acting as a redox-sensor in this case and support for this has recently been provided by the demonstration that ATM functions at the peroxisome to induce pexophagy in response to reactive oxygen species (ROS) (12, 13) . Oxidative stress has long been a feature of A-T with reports of elevated levels of ROS and increased sensitivity to ROS-generating agents in A-T cells and Atm-deficient mice (14) (15) (16) . While ATMdeficient mice do not exhibit neurodegeneration, cerebellar Purkinje cells show evidence of oxidative damage and their survival in vitro can be enhanced by antioxidants (17) . Furthermore, oxidative damage to lipids and DNA is markedly increased in lymphocytes from A-T patients (18) . In addition, there is emerging evidence for a role for inflammation in the clinical phenotype of A-T, including increased risk of diabetes, cardiovascular disease, lung disease, and autoimmunity (19) (20) (21) . It seems likely that defective DNA repair contributes to this since loss of ATM leads to the accumulation of DNA in the cytoplasm, constitutive production of type I interferon (IFN), elevated expression of pattern-recognition receptors and downstream signalling (22) . This in turn may prime the innate immune system to over respond to microbial infection leading to inflammatory changes as observed in A-T (21) . Furthermore, loss of ATM in a Drosophila model of A-T leads to elevation of expression of innate immune response genes in glial cells (23) . What remains uncertain is the contribution dysregulated inflammation may make to the neurodegenerative phenotype in A-T.
We generated a rat model which recapitulates part of the neurodegenerative phenotype described in A-T (see Supplementary Material, Table S1 for autopsy references). Loss of ATM led to accumulation of cytoplasmic DNA and increased cytokine production in the CNS as well as progressive activation of microglia. Microgliosis and loss of motor neurons in the spinal cord accompanied hind limb paralysis. Betamethasone, a glucocorticoid steroid with anti-inflammatory properties (24) , has been used previously in short-term trials in A-T patients and resulted in improved motor co-ordination during the course of treatment. However, the gains made were lost when treatment ceased and the mechanism by which betamethasone improved these symptoms in patients remains unclear.
Oral treatment of Atm -/-rats with betamethasone prevented microglial activation and significantly decreased inflammation, providing evidence that neuroinflammation contributes to the neurodegenerative phenotype in A-T and that betamethasone may be able to improve symptoms in A-T patients by controlling inflammation.
Results

Generation and characterization of Atm knockout rats
To generate Atm-deficient (Atm -/-) rats we employed SigmaAldrich Zinc Finger Nuclease Technology (ZFNs; see supplemen tary methods for details) to produce a custom designed ZFN with a specific binding/cleavage site in Atm Exon 13 (Fig. 1A) . ZFN mRNA was microinjected into the male pronucleus of a fertilised egg and transferred into a pseudopregnant foster mother (Supplementary Material, Fig. S1A ). Of the 15 pups screened one had a 8bp deletion at the cleavage site predicted to cause a premature stop codon in exon13. Genotyping by PCR was established to identify Atm -/-rats, and they were observed in the expected Mendelian ratios (Fig. 1B) . There was no detectable ATM protein in Atm -/-rat tissue (Fig. 1C) . Atm -/-rats looked grossly normal and were a similar size to littermates from birth through to weaning (i.e. 3 weeks of age see Fig. 1D and Supplementary Material, Fig. S1B ). As these Atm -/-rats aged, it became evident that only the male Atm -/-rats showed reduced weight gain compared to their wildtype littermates (Fig. 1D ). This may be due to sexual dimorphism in regulation of growth hormone and a greater effect of the loss of testosterone regulation in male rats compared to oestrogen regulation in female rats. As expected, cells from Atm -/-animals displayed a defect in DNA damage induced signalling as measured by ATM autophophorylation in response to exposure of ionizing radiation (IR) (Fig. 1C) . In addition IR-induced phosphorylation of a downstream signalling substrate, KAP1, was also defective (Fig. 1E) . We also generated rat embryonic fibroblasts (REFs) to examine the radiosensitivity of cells from these animals, Atm -/-REFs had a slower growth rate than wildtype (Atm
) cells with heterozygous (Atm þ/-) cells having an intermediate phenotype (Fig. 1F) .
Radiosensitivity of the cells was determined using a clonogenic survival assay ( mice (25, 26) . These data show that Atm -/-rats as expected, do not express the ATM protein and consequently have defects in the response to DNA damage and are highly sensitive to ionising radiation.
Atm
-/-rats recapitulate the majority of the disease phenotype of A-T patients Atm -/-rats had a significantly shorter lifespan than their wild-
) littermates; all Atm -/-rats died by 13 months, a time at which all Atm þ/þ rats were still alive ( Fig. 2A ).
Interestingly female rats had a significantly shorter lifespan than their male littermates (Fig. 2B ). This gender bias has not previously been reported for Atm -/-mice or A-T patients. We performed an analysis of autopsies of A-T patients in the literature (Supplementary Material, Table S1 ) and showed that the average life span in these patients was 5 years shorter for female patients than male patients (Fig. 2C) , indicating that the lifespan difference observed in the Atm -/-rats was reflective of A-T patient phenotype, enhancing its relevance as an animal model for A-T. A-T patients also have a strongly increased risk of developing lymphomas and leukaemias (27) . Atm -/-rats also developed lymphomas and occasional solid tumours similar to the cancer types seen in A-T patients. Tumours were excised, fixed in formalin and stained with haematoxylin and eosin and examined for confirmation of lymphoma development ( Fig. 2D and E). Upon histological analysis, it was clear that the majority of animals (>90%) showed some lymphoma or leukaemia development even if only early stages of the disease were detected (Fig. 2G ). These data fit with previous studies showing an important role for ATM in responses to oxidative stress (16) . No sexual dimorphism was detected in this phenotype or in any of the other cellular processes studied below unless indicated. A-T is also characterised by immunodeficiency (32) and ATM has been shown to be required for efficient class switch recombination in B cells (33, 34) , while ATM deficiency results in a defect in thymocyte maturation that is associated with decreased efficiency of V-J rearrangement of the T-cell receptor (TCR) alpha locus, accompanied by increased frequency of unresolved TCR J-alpha coding end breaks (35) . Atm -/-rats also showed evi- Combined these data indicate that the Atm -/-rats recapitulate most aspects of the A-T phenotype. Therefore the Atm -/-rats are an experimentally tractable in vivo model of A-T, which can be utilised to study cellular and molecular disease processes in this disorder.
Neurological abnormalities in Atm -/-rats
Spinal cord While the neuropathological hallmark of A-T is primarily diffuse cortical cerebellar degeneration it is evident from increased numbers of autopsies that changes to the CNS are more diffuse, affecting other regions of the brain including the substantia nigra, basal ganglia and brain stem (27) . Widespread severe changes to the spinal cord, more evident with age, are also observed which include thinning of the cord, anterior cell degeneration, demyelination of the gracile fasciculi, gliovascular malformations, loss of axons and variable increased presence of microglia (36, 37) . The most striking phenotype that we observed was progressive weakening to loss of the use of the hind limbs and tail and paralysis (Supplementary Materials, Videos S1-S3).
For the cohort of Atm -/-rats at the point of culling, approximately 50% of animals showed paralysis and 50% showed external signs of tumour development (such as hunching and difficulty breathing as seen in Atm -/-mice with thymomas (25,31)) (Paralysis:Tumour % ratios; Females 60:40, Males 40:60).
Since we observed hind-leg paralysis in Atm -/-rats, we counted the number of motor neurons present within the lateral motor columns of Atm -/-and Atm þ/þ rats (see supplementary methods for details). Atm -/-rats had reduced numbers of motor neurons compared to Atm þ/þ littermates at the onset of paralysis ( Fig. 3A and B). This loss of motor neurons was progressive with a smaller but detectable loss in pre-disease animals compared to sick animals ( (Fig. 3C) . Microglia, the macrophages of the CNS, play important roles in the development and control of neurodegenerative diseases (38) . Enhanced activation of microglia can lead to neuronal cell death or excessive pruning of axons leading to degeneration of axon connectivity (39) .
Cerebellum
The most prominent neurological characteristic in A-T patients is the presence of cerebellar atrophy and loss of Purkinje neurons (40) . However when we looked at the cerebellum of Atm -/-rats, we did not see a gross difference in brain size or morphology (Supplementary Material, Fig. S5A ), nor was there a significant difference in the number or distribution of Purkinje cells or in the thickness of the molecular layer of Atm -/-rats compared to Atm þ/þ littermates ( Fig. 4A and B) . We further looked for differences in arborisation of Purkinje cells using Golgi Cox staining but saw no significant differences in Purkinje cell morphology from Atm þ/þ and Atm -/-animals (Supplementary Material, Fig. S5B ).
We examined the brains of Atm -/-rats for evidence of unrepaired DNA damage. Brain sections were analysed by immunofluorescence for the presence of phosphorylated H2AX (cH2AX), which marks the sites of unrepaired DNA double-strand breaks (11) . Atm -/-rat brains had significantly more unrepaired DNA damage than Atm þ/þ rat brains ( Fig. 4C and D) . Further, when we stained sections of the cerebellum from Atm -/-and þ/þ rats with antibodies against double-stranded DNA (dsDNA), neurons including Purkinje cells in Atm -/-rats showed a strong signal for DNA in the cytoplasm ( Fig. 4E and H) . Staining for singlestranded DNA was similarly detected in the cytoplasm of cells in Atm -/-cerebellum but not in Atm þ/þ littermates ( Fig. 4F and H). In keeping with the presence of DNA in the cytoplasm in Atm -/-cerebellum staining for IFNb was also evident in these tissues but not in Atm þ/þ rats ( Fig. 4G and H) . When the intensity of the staining was quantified it was clear that the number of cells positive for ds and ss DNA and IFNb increased as the rats aged and disease progressed. These data demonstrate that, while there appears to be no loss of Purkinje cells in the cerebellum of Atm -/-rats, these cells are characterized by the presence of cytoplasmic DNA and induction of IFNb. We also investigated the activation of microglia, We stained cerebrum and cerebellum sections of rat brains with Iba-1 antibody to examine microglial number and activation status. The majority of microglia in the Atm þ/þ cerebellum were observed to be resting as evidenced by a ramified state with clear presence of projections (Fig. 5A, left panel) , whereas Atm -/-rats showed significantly increased activation of microglia (rounded or amoeboid appearance, Fig. 5A right panel see supplementary methods for details). Quantitation of the percentages of activated microglia (activated microglia/total microglia) is presented for the cerebral cortex ( Fig. 5B ) and cerebellum ( Fig. 5C) , showing a significant increase in microglia activation from predisease in the cerebral cortex and in older animals in the cerebellum. A significant decrease in the number of microglia in the cerebral cortex was evident for Atm -/-rats, but not so for the cerebellum ( Fig. 5D and E respectively, and representative images in Supplementary Material, Fig. S5C ). Microglia activation was further analysed in young healthy animals (2 months), pre-disease animals (asymptomatic animals 5 months) and symptomatic/sick animals (>5 months) to monitor changes with disease progression (Fig. 4B and C) . Alterations in microglia activation correlated with the severity of disease progression; in (F,G) measurement of ROS production by DCFDA (f) and mitochondrial membrane potential by TMRM (see methods) (g) Atm -/-(grey bars) and Atm þ/þ (black bars) splenocytes were treated with hydrogen peroxide (H 2 O 2 ) for the indicated times. Bars show the mean 6 SEM from three independent experiments (n ¼ 3). P-values calculated using student t-test. **p < 0.01, ***p < 0.001.
young healthy Atm -/-animals there was little detectable difference in either number or activation state of microglia, by 5 months a small but significant increase in activation and loss of microglia was observed, which was further exacerbated in rats showing overt paralysis symptoms. These data suggest that microglial activation is a key part of disease progression and not a response at endpoint. In the case of the cerebral cortex there was a significant increase in activated microglia in 5 month old Atm -/-rats as well as animals that showed neurodegenerative symptoms. Given the correlation of microglial state with disease, we examined initial influx of microglia into the brain during development. Microglia derive from the yolk sac and establish in the brain shortly after birth therefore we examined microglial populations in day 1 and day 18 pups (Supplementary Material, Fig. S5D and E). There was no difference in the microglia populations in Atm -/-and Atm þ/þ animals during development, indicating that the microglia populations establish normally but become activated in a progressive manner during the predisease phase and progression of disease. These data combined indicate that during the course of disease Atm -/-rats have dysregulation of the microglial compartment and cytosolic DNA induced IFNb production throughout the brain, cerebellum and spinal cord combined with severe loss of motor neurons in the lumbar lateral motor column.
Telangiectasia
Telangiectasia are one of the cardinal features of A-T, first noticed in the angles of the eye and spreading horizontally across the exposed portion of the bulbar conjunctivae (27) . They represent dilated blood vessels, and it remains unclear why they arise but could be due to exposure to light and/or resulting from irritation. We observed that Atm -/-rat eyes also showed obvious signs of disease including production of porphyrin (red secretion from the eyes) and pale eye colour (Supplementary Material, Fig. S6A ). Production of porphyrin is a sign of stress and disease in rats and was observed in Atm Fig. S6D ). In the rats the consistent activation of macroglial cells in the retina compared to limited activation in the cerebrum and cerebellum with the reverse effect observed for microglia, suggests that a different disease mechanism is operating within the microenvironment of the eye compared to the rest of the CNS.
Neuroinflammation and altered innate immune responses in microglia from Atm -/-rats
Given that IFNb up-regulation and widespread microglia activation were observed, we looked for evidence of broader neuroinflammation and dysregulation of inflammatory responses in Atm -/-rats. RNA was isolated from the brain and cerebellum of sick Atm -/-and Atm þ/þ rats, cDNA synthesis was performed and real time PCR used to measure the mRNA levels of IFNb, IL-1b and ccl2 (Fig. 6A) . As expected from immuno-histological (IHC) stains, the level of IFNb was increased in the cerebellum of Atm -/-rats. Ccl2 was significantly decreased in Atm -/-rat brains, rats. Quantification of IHC staining from at least 3 independent animals at each timepoint. Bars show the mean 6 SEM. P-values calculated by unpaired t-test using GraphPad Prism 5, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
ccl2 is an important chemokine for microglia recruitment and its decrease may contribute to the decrease observed in microglia during disease progression. IL-1b was statistically significantly increased in the cerebellum of Atm -/-rats. The IL-1b protein level was also significantly increased in the cerebellum and spinal cord as determined by IHC staining (Fig. 6B and Supplementary Material, Fig. S7A and B) . IL-1b staining could be observed in both neuronal and glial cells. We also examined expression of an addition M1 marker TNFa and two M2 markers IL-10 and TGFb in brain and cerebellum and confirmed that similar to IL-1b and IFNb the additional M1 marker TNFa was significantly increased in Atm -/-rat brain and cerebellum Fig. S7C ). Interestingly, there was also an increase in expression of the M2 markers (Supplementary Material, Fig. S7C ), this has been observed previously in microglia (42) and may represent a combined response to inflammatory stimuli and an attempt to modulate this response to decrease injury to neuronal tissue. A major transcription factor required for expression of IL-1b and TNFa is NF-jB. Expression of the p65 subunit of NF-jB was up-regulated in the spinal cord of Atm -/-rats, (Fig. 6C and Supplementary Material, Fig. S7D ).
Furthermore, p65 was clearly localised to the nucleus of large neuronal cells such as motor neurons, indicating that it is activated to induce gene expression. Glial cells also had elevated (B) and the cerebellum (C) of Atm þ/þ and Atm -/-rats early in life (young 2 months of age), at pre-disease Atm -/-(5 months of age with no detectable loss of motor function), and when displaying loss of motor function (sick Atm -/-) or matched older Atm þ/þ (>6 months). The density of microglial in cerebral cortex (D) and cerebellum (E) was also quantified. Columns show the mean 6 SEM from at least 3 animals (n ¼ 3). Statistical significance determined by student t-test (*p < 0.05, ***p < 0.001, ns ¼ not significant).
p65 expression although it was less clear how much p65 had translocated to the nucleus of these smaller cells. Given that increasing microglial activation was observed during disease progression in the Atm -/-rats, we queried whether there was a specific defect in glia that was independent of the inflammation in neurons. To address this question, we used CD11b antibody to isolate microglia from the brains of young Atm -/-and Atm þ/þ rats. These microglia cells were then grown in tissue culture for 5-7 days. We first determined whether cytosolic DNA and IFNb could be observed in these isolated cells.
In line with what was observed for neurons, microglia from Atm -/-rats stained positive for dsDNA in the cytoplasm of cells (Fig. 6D) . The isolated microglia from these rats also showed positive staining for IFNb (Fig. 6E ) Further levels of phosphorylated TBK1 (indicative of STING activation) were increased in isolated microglia (Supplementary Material, Fig. S7E ). IjBa, a protein which normally retains NF-jB in an inactive state in the cytoplasm, was detected by Western blotting. IjBa levels were reduced in Atm -/-microglia, indicating that constitutive NF-jB activation was occurring (Supplementary Material, Fig. S7F ). The continuous activation of innate immune response pathways may either lead to priming of the cells resulting in an enhanced response to later signal or can result in 'tolerance' which would suppress later responses (43) . To determine which was occurring in microglia from Atm -/-rats, these glial cells were exposed to LPS to assess their inflammatory response. Microglia from Atm -/-rats induced significantly greater levels of IL-6, IL-8 and IL-1b in response to LPS compared to cells from Atm þ/þ littermates at the 2h after exposure (Fig. 6F ). Upon LPS treatment IjBa was not detectable in either sample. These data indicate that loss of ATM leads to an exacerbated response to toll-like receptor activation in microglia, potentially due to continuous activation of the NF-jB signalling pathway.
Inhibition of inflammation increases lifespan and stalls onset of neurodegenerative disease in Atm -/-rats
Amelioration of neurological signs, assessed by Scale for the Assessment and Rating of Ataxia (SARA), has been reported with oral betamethasone and dexamethasone encapsulated in autologous erythrocytes (24, 44) . Although the mechanism is undescribed, it may be due to the anti-inflammatory properties of these steroids. We hypothesised that a similar effect might be achieved in Atm -/-rats. In order to test this, we treated Atm -/-rats shortly after weaning with a daily low oral dose (0.03mg/kg/ day) of the anti-inflammatory drug betamethasone. This treatment extended the lifespan of both male and female Atm -/-rats by approximately two-fold (Fig. 7A) . Of interest, only one of the treated animals developed paralysis of the hind limbs with others eventually succumbing to lymphoma development. Loss of motor neurons in the spine was significantly reduced by treatment with betamethasone, but not restored to levels seen in Atm þ/þ rats (80% of Atm þ/þ see Fig. 7B and Supplementary
Material, Fig. S8A ). As a second criterion of protection, we measured microglial activation, which was significantly reduced in both the spinal cord and brain by betamethasone treatment (Fig. 7C and Supplementary Material, Fig. S8B and C) . The loss of microglial cell numbers observed in the brain of Atm -/-rats was also attenuated (Fig. 7D) . However, accumulation of ds and ssDNA in the cytoplasm of cells was not significantly reduced in betamethasone treated animals ( Fig. 7E and Supplementary Material, Fig. S8D and E and quantification in Fig 4H and Fig4E) . These data suggest that betamethasone treatment can provide for a significant level of motor neuron protection and extended survival, presumably via is anti-inflammatory actions; however, it does not correct the defect in neurons leading to the accumulation of cytosolic DNA. This conclusion is supported by data showing that there is significantly less IL-1b, IFNb and NF-jB p65 expression detected in Atm -/-rats treated with betamethasone compared to untreated animals of the same age ( Fig. 7E  and F and Supplementary Material, Fig. S8F and G and quantification for IFNb Fig 4H and Supplementary Material, S4E and IL-1b Fig. 6B and p65 Fig. 6C ). We then examined the direct inflammatory components being altered in response to betamethasone treatment. Bone marrow derived macrophages (BMM) were differentiated from Atm -/-and wildtype rats and treated overnight with betamethasone prior to LPS activation and cytokine production measured by realtime PCR (Fig 7G) . As seen for isolated microglia IFNb production in response to LPS was significantly elevated in BMM from Atm -/-rats compared to wildtype littermates. Betamethasone treatment decreased the induction of IFNb to the same level as wildtype cells, thereby suppressing the hyperactivation of Atm -/-cells in response to inflammatory stimuli. Interestingly betamethasone treatment also increased expression of anti-inflammatory IL-10 production in response to LPS. IL-10 is known to be neuroprotective and this combination of decreased IFNb and increased IL-10 may be one mechanism by which betamethasone is protecting Atm -/-rats from motor neuron loss. We also measured IjBa levels as these were decreased in isolated microglia (Supplementary Material, Fig S8H) . While the basal level of IjBa was not changed at basal level between BMM from Atm -/-and wildtype rats, betamethasone treatment increased IjBa levels suggesting it suppresses activation of the NF-jB pathway. Interestingly, these data also suggest that the cell intrinsic inflammation is greater in microglia than in BMM as basal differences were not observed in BMM. This may explain why the neuroinflammation is more prominent than systemic inflammation in Atm -/-rats.
Discussion
Neurodegeneration is the most debilitating aspect of ataxiatelangiectasia but, due to the limitations of Atm -/-mice and human cell models, the mechanisms contributing to neurodegeneration in A-T have been poorly understood. Unlike Atm -/-mouse models, Atm -/-rats show clear signs of neurodegeneration, most evident in the spinal cord. Atm -/-rats developed a 'paralysis phenotype' appearing as early as 4 months of age, with loss of hind limb movement likely to be caused by the loss of motor neurons in the lumbar region of the spinal cord. While A-T is primarily characterized by cerebellar atrophy, other regions of the CNS are also affected (27) . Neuropathological autopsies on multiple patients with A-T reveal damage not only to the cerebellum but also to the brainstem and spinal cord (36, 37) . Spinal cord damage was most evident as severe posterior column demyelination and degeneration, and more moderate lateral cord and anterior horn degeneration of patients. A gradient of severity of anterior horn motor neuron cell loss from cervical to lumbar levels was observed in patients. These data suggest that part of the A-T neurodegenerative phenotype involves pathogenic changes causing spinal cord degeneration. Our observations in the Atm -/-rat model are consistent with this.
Associated with the loss of motor neurons was marked microgliosis and microglial activation in the brain and lumbar region of the spinal cord. This dysregulation of the microglial compartment could be seen to progress through the stages of disease Discrepancies between the Atm -/-rats and A-T patients might be accounted for by species differences between rats and humans that result in the spinal cord being more heavily involved in the rats and the cerebellum being the initial site of severe disease progression in humans, with spinal cord degeneration occurring later, as has been observed in some A-T patient autopsies (see Supplementary Material, Table S1 ). Differences between the species could be either in the neuronal compartment and the susceptibility of individual neurons to DNA damage and consequent accumulation of cytosolic DNA, or they could be in the immune system itself as there are a number of receptor and cytokine families that are poorly conserved between rats and humans (45, 46) Alternatively, there may be environmental factors which contribute to the profound cerebellar atrophy observed in A-T patients that are not recapitulated in the strictly controlled environment of an animal house. For example, it was previously shown that LPS treatment of Atm -/-mice could induce cell death in Purkinje cells, suggesting that a second signal is required to induce neurodegeneration even in genetically susceptible animals (47) . Generally, laboratory animals are not exposed to infections, which could produce systemic inflammation. By contrast such infections are unfortunately common in A-T patients and may exacerbate neurodegenerative progression. Despite this difference between patients and Atm -/-rats, it is clear that the Atm -/-rat is a significant improvement on Atm -/-mouse models in that there is clear evidence of neurodegenerative pathways, which can be studied to provide insights into the disease mechanisms in A-T. More recently Beraldi et al. (48) engineered a porcine model of A-T which revealed some evidence for a decrease in Purkinje cell numbers and motor deficits but not neurodegeneration. During the development of neurodegeneration in Atm -/-rats,
we identified the accumulation of cytosolic DNA in both neurons and glia as a possible initiating event. This phenomenon has recently been described in Atm -/-mice and A-T patient fibroblasts (22) . Excessive DNA damage burden caused by the inability of Atm -/-cells to process DNA double-strand breaks resulted in the accumulation of double and single-stranded DNA in the cytoplasm of cells. This DNA appears to have been detected by the cGAS-STING pathway activating both TBK1 and NF-jB resulting in increased IFNb production (Fig. 8) . We also observed elevated IFNb in the brain and spinal cord of Atm -/-rats as well as increased IL-1b production. IL-1b production can also occur in response to cytosolic DNA via STING and NF-jB activation and transcriptional up-regulation of IL-1b mRNA ( Fig. 6A and Supplementary Material, S7D-F) (49) . IL-1b is produced in a proform, and this pro-form can be converted to the active form via processing by caspase-1; appropriate caspase-1 activation can be induced by the AIM2 inflammasome in response to cytosolic dsDNA (50) . Whether this pathway contributes to disease progression is the subject of ongoing investigations, but of particular interest is the type and size of DNA released into the cytoplasm in response to DNA damage. Hartlova and colleagues detected predominantly ssDNA and small 300bp dsDNA (22) . While these types of DNA can activate the cGAS-STING pathway, they are not optimal ligands for the AIM2 inflammasome, which requires a sufficient length of dsDNA for clustering of multiple receptors to induce inflammasome activation (optimal length >500bp), though at high enough concentrations, even small dsDNA can be sufficient to induce caspase-1 activation (50). This suggests that initially the DNA detected in the cytoplasm of cells will predominantly induce TBK1 and NF-jB activation (Supplementary Material, Fig. S7D-F) and IFNb production ( Fig. 6E ), but as the amount accumulates, inflammasome activation, production of active IL-1b and cell death will also occur ( Fig. 8 ) (50) . Primed microglia then have an exacerbated response to components of the dying cells further increasing the inflammatory microenvironment and leading to greater dysfunction and death of neurons. Once commenced, this neuroinflammatory loop is self-aggravating and leads to the progressive neurodegeneration observed in Atm -/-rats.
Studies in Drosophila also highlighted the importance of NFjB signalling in neurodegeneration caused by ATM loss. Atm -/-flies, which lack ATM kinase activity, show the development of movement difficulties and neurodegeneration. If these mutant flies are crossed with those with a Relish (a Drosophila NF-jB subunit) mutation, neurodegeneration is inhibited (51) . ATM is also known to control NF-jB activity in mammals by phosphorylating the p65 subunit. ATM-dependent phosphorylation on Ser547 of p65 acts to limit pro-inflammatory gene expression following genotoxic stress in HEK293 cells (52) . We further showed that microglia isolated from healthy Atm -/-rat brains responded to LPS treatment with increased cytokine production (Fig. 6F) , including those utilising NF-jB induced gene expression and known to be affected by ATM-dependent phosphorylation of p65. These data suggest that microglia lacking ATM might also respond excessively to exposure to endogenous stimuli released from dying cells. Activation of both inflammasomes and toll-like receptors (TLRs) has been shown to play an important role in other neurodegenerative diseases. b-amyloid aggregates present in AD can activate both inflammasomes (via Nod-like receptor protein 3 (NLRP3)) and TLRs 2 and 4 via binding to their co-receptor CD14 (53, 54) . Nlrp3
-/-and Caspase 1 -/-mice were largely protected from onset of disease symptoms in a mouse model of Alzheimer's disease (55) . TLR2 and 4 have also been implicated in microglial activation in mouse models of ALS (56) .
The percentage of cells showing p65 translocation to the nucleus (indicative of activation of the pathway) was quantified. Quantification of IHC staining from at least 3 independent animals at each timepoint. Bars show the mean 6 SEM. P-values calculated by unpaired t-test using GraphPad Prism 5, * p < 0.05, **p < 0.01, ****p < 0.0001.
In motor neurons p65 was clearly nuclear indicating active NF-jB signalling. (D) Microglia were isolated from Atm -/-and Atm þ/þ animals using magnetic beads and antiCD11b. Cells were grown in culture for up to 1 week. Cells were stained with anti-dsDNA (green) and nuclei stained with DAPI (blue). Atm -/-microglia showed clear development of dsDNA foci. (E) Freshly isolated microglia were fixed in 100% methanol then cytospun and stained with anti-IFNb (green) and DAPI (blue). (F) Isolated microglia were treated with 5ng/ml LPS and harvested at 2 and 8h post-treatment for RNA isolation. Real time PCR was used to measure cytokine mRNA levels following LPS treatment and compared to the expression of a pool of housekeeping genes. Atm -/-microglia (grey bars) had a greater induction of IL-1b, IL-6 and IL-8 mRNA at 2h after LPS treatment than Atm þ/þ microglia (black bars). Bars show the mean 6 SEM from three independent experiments (n ¼ 3). P-values were calculated using a ratio t-test in GraphPad Prism 6. *p < 0.05. All IHC images in this figure are representative of at least 3 independent animals. These diseases are proposed to have an inflammatory loop established between damaged neurons and the glial compartment. Here, we describe a similar disease model. There is currently no effective treatment for the progressive neurodegeneration in A-T. However, improvement in cerebellar function was demonstrated in A-T patients after short-term oral betamethasome treatment (57) . In a follow-up study Broccoletti and colleagues demonstrated that betamethasone significantly improved neurological function at minimal dosage (0.03 mg/kg/day) (24) . Further doses as low as 0.01 mg/kg/day had appreciable effects reducing the risk of side-effects. Infusions of autologous erythrocytes loaded with dexamethasone (EryDel) into A-T patients in an extended study (24 months) showed a continuous improvement of symptoms compared to commencement indicating that this delivery system was safe and well tolerated (58) . However, neurological deterioration was observed after discontinuation of the trial. In this study, we showed that the neuroinflammatory loop could be broken in the Atm -/-rats by treatment with low dose betamethasone. Animals that were treated with betamethasone still showed accumulation of cytosolic DNA. However, they did not have elevated levels of IL-1b or IFNb production nor did they display the significant increase in microglial activation. Betamethasone can act as to suppress inflammation by limiting NF-jB activation (59) as well as protecting post-mitotic neurons from cell death (60) . These combined effects can prevent a neuroinflammatory loop reaching the point where symptomatic neurodegeneration is observed. As this type of neuroinflammatory loop has been proposed as the basis of a number of more common neurodegenerative disorders, our findings in the 'genetically simple' Atm -/-rat may have broader implications for understanding and treating more common neurodegenerative diseases.
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